Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.creator | Baraibar-Argota, I. (Iosune) | - |
dc.creator | Martin-Romano, P. (Patricia) | - |
dc.creator | Fernandez-Sanmamed, M. (Miguel) | - |
dc.creator | Rodriguez-Ruiz, M.E. (María Esperanza) | - |
dc.creator | Melero, I. (Ignacio) | - |
dc.creator | Resano, L. (Leyre) | - |
dc.creator | Ortega-Montes, A. (Ana) | - |
dc.creator | Ponz-Sarvise, M. (Mariano) | - |
dc.creator | Castañon-Alvarez, E. (Eduardo) | - |
dc.date.accessioned | 2023-02-08T09:37:51Z | - |
dc.date.available | 2023-02-08T09:37:51Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Baraibar-Argota, I. (Iosune); Martin-Romano, P. (P.); Fernandez-Sanmamed, M. (Miguel); et al. "Chemotherapy after immunotherapy failure in patients with advanced gastrointestinal tumors". Annals of oncology. 29 (Supl. 6), 2018, 21 - 22 | es |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://hdl.handle.net/10171/65316 | - |
dc.description.abstract | First line therapies usually induce the longest progression free survival (PFS) in metastatic gastrointestinal cancers (GIC) as compared to subsequent lines of treatment. However, immunotherapy (IT) due to its mechanisms of action could influence sensitivity to conventional cancer therapy (CCT) after progression to IT and thereby, influence both tumor growth rate (TGR) and PFS. We have studied TGR and PFS before and after participation in phase I IT trials. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Progression free survival (PFS) | es_ES |
dc.subject | Gastrointestinal cancers (GIC) | es_ES |
dc.title | Chemotherapy after immunotherapy failure in patients with advanced gastrointestinal tumors | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.identifier.doi | 10.1093/annonc/mdy314.002 | - |
dadun.citation.endingPage | 22 | es_ES |
dadun.citation.number | Supl. 6 | es_ES |
dadun.citation.publicationName | Annals of oncology | es_ES |
dadun.citation.startingPage | 21 | es_ES |
dadun.citation.volume | 29 | es_ES |
Ficheros en este ítem:
Estadísticas e impacto
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.